ZB
TECH icon

Zions Bancorporation’s Bio-Techne TECH Stock Holding History

Zions Bancorporation’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.79M Buy
38,728
+8,533
+28% +$627K 0.18% 116
2024
Q3 		$2.41M Buy
30,195
+4,450
+17% +$334K 0.18% 111
2024
Q2 		$1.84M Sell
25,745
-925
-3% -$68.1K 0.15% 115
2024
Q1 		$1.88M Buy
26,670
+1,886
+8% +$135K 0.14% 130
2023
Q4 		$1.91M Buy
24,784
+1,456
+6% +$95.9K 0.13% 123
2023
Q3 		$1.59M Buy
23,328
+970
+4% +$76.6K 0.14% 123
2023
Q2 		$1.83M Buy
22,358
+136
+0.6% +$10.9K 0.15% 106
2023
Q1 		$1.65M Buy
22,222
+129
+0.6% +$9.94K 0.14% 109
2022
Q4 		$1.83M Buy
22,093
+2,449
+12% +$194K 0.14% 98
2022
Q3 		$1.4M Sell
19,644
-308
-2% -$26.6K 0.15% 111
2022
Q2 		$1.73M Buy
19,952
+3,272
+20% +$307K 0.17% 90
2022
Q1 		$1.81M Buy
16,680
+4,032
+32% +$416K 0.16% 90
2021
Q4 		$1.64M Buy
12,648
+2,900
+30% +$356K 0.14% 85
2021
Q3 		$1.18M Buy
9,748
+852
+10% +$104K 0.12% 99
2021
Q2 		$1M Buy
8,896
+1,008
+13% +$106K 0.1% 106
2021
Q1 		$753K Buy
7,888
+1,080
+16% +$98.5K 0.09% 110
2020
Q4 		$540K Buy
6,808
+340
+5% +$24.6K 0.07% 116
2020
Q3 		$401K Hold
6,468
– – 0.06% 129
2020
Q2 		$427K Buy
6,468
+536
+9% +$32.1K 0.06% 120
2020
Q1 		$281K Buy
5,932
+260
+5% +$13K 0.05% 131
2019
Q4 		$311K Sell
5,672
-784
-12% -$41.1K 0.04% 144
2019
Q3 		$316K Buy
6,456
+108
+2% +$5.42K 0.05% 160
2019
Q2 		$331K Buy
6,348
+376
+6% +$18.9K 0.05% 144
2019
Q1 		$296K Buy
5,972
+112
+2% +$5.04K 0.05% 153
2018
Q4 		$212K Sell
5,860
-128
-2% -$5.35K 0.16% 70
2018
Q3 		$306K Sell
5,988
-124
-2% -$5.49K 0.07% 119
2018
Q2 		$226K Sell
6,112
-32
-0.5% -$1.22K 0.16% 84
2018
Q1 		$232K Buy
6,144
+360
+6% +$12.7K 0.05% 118
2017
Q4 		$187K Sell
5,784
-108
-2% -$3.43K 0.03% 159
2017
Q3 		$178K Buy
+5,892
New +$175K 0.03% 286

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Zions Bancorporation's TECH Position: Q4 2024 in Review

Zions Bancorporation increased its Bio-Techne (TECH) stake by 28% in Q4 2024, buying an estimated $627K and bringing the position to 38,728 shares worth $2.79M. The position accounts for 0.18% of the portfolio, ranked #116.

Zions Bancorporation first reported a position in TECH in Q3 2017 and has held it in 30 quarters since. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

  • Zions Bancorporation held 38,728 shares of Bio-Techne worth $2.79M as of Q4 2024.
  • Zions Bancorporation bought 8,533 Bio-Techne shares in Q4 2024, an estimated $627K.
  • Bio-Techne made up 0.18% of Zions Bancorporation's portfolio in Q4 2024, its #116 holding.
  • Zions Bancorporation first reported a position in Bio-Techne in Q3 2017 and has held it in 30 quarters since.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.